Skip to main content
main-content

04.11.2017 | Breast Cancer Screening and Imaging (HTC Le-Petross and BE Adrada, Section Editors) | Ausgabe 4/2017 Open Access

Current Breast Cancer Reports 4/2017

Axillary Nodal Staging with Contrast-Enhanced Ultrasound

Zeitschrift:
Current Breast Cancer Reports > Ausgabe 4/2017
Autoren:
Nisha Sharma, Karina Cox
Wichtige Hinweise
This article is part of the Topical Collection on Breast Cancer Screening and Imaging

Abstract

Purpose of Review

Axillary staging in the context of breast cancer is a contentious topic due to the varied practices across UK, Europe, and America. The ACOSOG Z0011 trial has questioned the role of axillary ultrasound in women with breast cancer. Published data has shown that women with ultrasound-positive lymph nodes have a worse prognosis than those with ultrasound-negative lymph nodes. Axillary ultrasound is limited as the sentinel lymph node (SLN) cannot be identified using B-mode ultrasound; however, with the advent of contrast-enhanced ultrasound (CEUS), this has now changed.

Recent Findings

The published literature has shown that the sentinel lymph node can be identified using CEUS. The rates are equivalent to blue dye alone but currently inferior to the dual technique of sentinel lymph node biopsy. There are several different contrast agents that can be used and the agents that remain in the sentinel lymph node for longer can identify areas of poor enhancement, allowing for targeted biopsy.

Summary

CEUS has the potential to revolutionize the way we manage the axilla in the future and may even replace surgical staging.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Onkologie

Kombi-Abonnement

Mit e.Med Onkologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Onkologie, den Premium-Inhalten der onkologischen Fachzeitschriften, inklusive einer gedruckten onkologischen Zeitschrift Ihrer Wahl. 

e.Med Gynäkologie & Urologie

Kombi-Abonnement

Mit e.Med Gynäkologie & Urologie erhalten Sie Zugang zu CME-Fortbildungen der beiden Fachgebiete, den Premium-Inhalten der Fachzeitschriften, inklusive einer gedruckten gynäkologischen oder urologischen Zeitschrift Ihrer Wahl.

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 4/2017

Current Breast Cancer Reports 4/2017 Zur Ausgabe

Systemic Therapies (M Liu and T Haddad, Section Editors)

Androgen Receptor-Targeted Therapy for Breast Cancer

Breast Cancer Screening and Imaging (HTC Le-Petross and BE Adrada, Section Editors)

DBT as a Screening Tool and a Diagnostic Tool

Systemic Therapies (M Liu and T Haddad, Section Editors)

Extended Adjuvant Aromatase Inhibitor Therapy in Post-Menopausal Women

Breast Cancer Screening and Imaging (HTC Le-Petross and BE Adrada, Section Editors)

How Effective Is Mammography as a Screening Tool?

Systemic Therapies (M Liu and T Haddad, Section Editors)

Pre-operative Endocrine Therapy

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise